Efficacy and Safety of Azilsartan Medoxomil Co-Administered With Chlorthalidone in Participants With Essential Hypertension
Public ClinicalTrials.gov record NCT00591773. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Double-Blind, Randomized, Placebo-Controlled Study to Evaluate the Efficacy and Safety of TAK-491 When Co-administered With Chlorthalidone in Subjects With Essential Hypertension
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to evaluate the efficacy and safety of azilsartan medoxomil, once daily (QD), co-administered with chlorthalidone in treating individuals with essential hypertension, compared to treatment with chlorthalidone alone.
Study identification
- NCT ID
- NCT00591773
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 551 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2007 (Type not available)
- Primary completion
- Mar 2009 (Actual)
- Completion
- Mar 2009 (Actual)
- Last update posted
- Apr 19, 2011
2007 – 2009
United States locations
- U.S. sites
- 46
- U.S. states
- 17
- U.S. cities
- 46
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Huntsville | Alabama | — | — |
| Not listed | Montgomery | Alabama | — | — |
| Not listed | Buena Park | California | — | — |
| Not listed | Huntington Beach | California | — | — |
| Not listed | Long Beach | California | — | — |
| Not listed | Mission Viejo | California | — | — |
| Not listed | Roseville | California | — | — |
| Not listed | Sacramento | California | — | — |
| Not listed | Westlake Village | California | — | — |
| Not listed | Coral Gables | Florida | — | — |
| Not listed | DeLand | Florida | — | — |
| Not listed | Fort Lauderdale | Florida | — | — |
| Not listed | Hollywood | Florida | — | — |
| Not listed | Miami | Florida | — | — |
| Not listed | Auburn | Maine | — | — |
| Not listed | Bingham Farms | Michigan | — | — |
| Not listed | Troy | Michigan | — | — |
| Not listed | Charlotte | North Carolina | — | — |
| Not listed | Huntersville | North Carolina | — | — |
| Not listed | Shelby | North Carolina | — | — |
| Not listed | Akron | Ohio | — | — |
| Not listed | Centerville | Ohio | — | — |
| Not listed | Cincinnati | Ohio | — | — |
| Not listed | Willoughby Hills | Ohio | — | — |
| Not listed | Zanesville | Ohio | — | — |
| Not listed | Norman | Oklahoma | — | — |
| Not listed | Oklahoma City | Oklahoma | — | — |
| Not listed | Eugene | Oregon | — | — |
| Not listed | Portland | Oregon | — | — |
| Not listed | Tualatin | Oregon | — | — |
| Not listed | Bensalem | Pennsylvania | — | — |
| Not listed | Feasterville | Pennsylvania | — | — |
| Not listed | Cranston | Rhode Island | — | — |
| Not listed | Simpsonville | South Carolina | — | — |
| Not listed | Kingsport | Tennessee | — | — |
| Not listed | Corpus Christi | Texas | — | — |
| Not listed | Houston | Texas | — | — |
| Not listed | Pearland | Texas | — | — |
| Not listed | San Antonio | Texas | — | — |
| Not listed | Salt Lake City | Utah | — | — |
| Not listed | Arlington | Virginia | — | — |
| Not listed | Burke | Virginia | — | — |
| Not listed | Richmond | Virginia | — | — |
| Not listed | Lakewood | Washington | — | — |
| Not listed | Olympia | Washington | — | — |
| Not listed | Port Orchard | Washington | — | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00591773, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 19, 2011 · Synced Oct 25, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00591773 live on ClinicalTrials.gov.